UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Consent Statement...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A...
ADVISORY, April 21, 2011 (GLOBE NEWSWIRE) -- What: Cephalon, Inc. (CEPH) will visit the NASDAQ...
Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders - Recommends Shareholders Reject Valeant's Consent...
MISSISSAUGA, Ontario, April 21, 2011 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today filed a revised...
Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders PR Newswire MISSISSAUGA, Ontario, April 21, 2011 MISSISSAUGA, Ontario, April...
Table of Contents REVISED PRELIMINARY CONSENT STATEMENT SUBJECT TO COMPLETION, DATED APRIL 21, 2011...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A...
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED...
MISSISSAUGA, Ontario, April 18, 2011 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today filed a revised...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.